AMP Capital Investors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-75,621
| Closed | -$19.9M | – | 821 |
|
|
2021
Q3 | $19.9M | Sell |
75,621
-15,408
| -17% | -$4.21M | 0.11% | 211 |
|
|
2021
Q2 | $22.4M | Sell |
91,029
-27,954
| -23% | -$5.88M | 0.11% | 225 |
|
|
2021
Q1 | $23M | Buy |
118,983
+8,876
| +8% | +$1.78M | 0.11% | 216 |
|
|
2020
Q4 | $23.1M | Sell |
110,107
-5,863
| -5% | -$1.17M | 0.12% | 201 |
|
|
2020
Q3 | $20M | Sell |
115,970
-7,267
| -6% | -$1.34M | 0.12% | 199 |
|
|
2020
Q2 | $23.2M | Buy |
123,237
+37,775
| +44% | +$6.18M | 0.15% | 167 |
|
|
2020
Q1 | $13.2M | Buy |
85,462
+16,551
| +24% | +$2.64M | 0.1% | 223 |
|
|
2019
Q4 | $10.7M | Buy |
68,911
+28,820
| +72% | +$4.15M | 0.06% | 356 |
|
|
2019
Q3 | $5.36M | Hold |
40,091
| – | – | 0.03% | 515 |
|
|
2019
Q2 | $4.83M | Sell |
40,091
-191
| -0.5% | -$21.2K | 0.03% | 531 |
|
|
2019
Q1 | $4.13M | Sell |
40,282
-24,291
| -38% | -$2.51M | 0.02% | 587 |
|
|
2018
Q4 | $7.24M | Sell |
64,573
-30,752
| -32% | -$3.29M | 0.05% | 402 |
|
|
2018
Q3 | $10.9M | Buy |
95,325
+59,429
| +166% | +$6.51M | 0.06% | 347 |
|
|
2018
Q2 | $3.72M | Sell |
35,896
-936
| -3% | -$94.7K | 0.02% | 609 |
|
|
2018
Q1 | $3.55M | Sell |
36,832
-842
| -2% | -$79.6K | 0.02% | 627 |
|
|
2017
Q4 | $3.19M | Hold |
37,674
| – | – | 0.02% | 665 |
|
|
2017
Q3 | $2.9M | Sell |
37,674
-7,051
| -16% | -$539K | 0.02% | 672 |
|
|
2017
Q2 | $3.45M | Hold |
44,725
| – | – | 0.02% | 616 |
|
|
2017
Q1 | $3.2M | Sell |
44,725
-15,400
| -26% | -$1.06M | 0.02% | 647 |
|
|
2016
Q4 | $3.75M | Sell |
60,125
-2,526
| -4% | -$155K | 0.02% | 599 |
|
|
2016
Q3 | $4.02M | Sell |
62,651
-20,185
| -24% | -$1.34M | 0.02% | 577 |
|
|
2016
Q2 | $5.14M | Buy |
82,836
+23,690
| +40% | +$1.4M | 0.03% | 469 |
|
|
2016
Q1 | $3.37M | Sell |
59,146
-12,200
| -17% | -$691K | 0.02% | 583 |
|
|
2015
Q4 | $3.88M | Sell |
71,346
-5,500
| -7% | -$310K | 0.03% | 551 |
|
|
2015
Q3 | $3.89M | Buy |
76,846
+15,957
| +26% | +$859K | 0.03% | 516 |
|
|
2015
Q2 | $3.38M | Buy |
60,889
+26,300
| +76% | +$1.66M | 0.02% | 564 |
|
|
2015
Q1 | $2.48M | Hold |
34,589
| – | – | 0.02% | 659 |
|
|
2014
Q4 | $1.96M | Hold |
34,589
| – | – | 0.01% | 740 |
|
|
2014
Q3 | $1.73M | Sell |
34,589
-44,222
| -56% | -$2.25M | 0.01% | 776 |
|
|
2014
Q2 | $4.13M | Buy |
78,811
+14,700
| +23% | +$729K | 0.03% | 553 |
|
|
2014
Q1 | $2.81M | Sell |
64,111
-30,359
| -32% | -$1.36M | 0.02% | 645 |
|
|
2013
Q4 | $4.46M | Sell |
94,470
-44,600
| -32% | -$2.26M | 0.03% | 536 |
|
|
2013
Q3 | $7.33M | Buy |
139,070
+30,149
| +28% | +$1.46M | 0.06% | 374 |
|
|
2013
Q2 | $5.09M | Buy |
+108,921
| New | +$5.17M | 0.04% | 475 |
|
Other funds holding RMD
OCBV
AMP Capital Investors's RMD Position: Q4 2021 in Review
AMP Capital Investors sold out of ResMed (RMD) in Q4 2021, closing a stake of 75,621 shares — an estimated $19.9M sold.
AMP Capital Investors first reported a position in RMD in Q2 2013 and held it in 34 quarters. The position peaked at $23.2M in Q2 2020. 724 funds tracked by Wall St. Rank hold RMD as of Q4 2021.
- AMP Capital Investors reported no remaining ResMed position as of Q4 2021 after selling out during the quarter.
- AMP Capital Investors sold 75,621 ResMed shares in Q4 2021, an estimated $19.9M.
- AMP Capital Investors first reported a position in ResMed in Q2 2013 and held it in 34 quarters.
- AMP Capital Investors's ResMed position peaked at $23.2M in Q2 2020.
- 724 funds tracked by Wall St. Rank held ResMed as of Q4 2021.
Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.